´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö : 2023-06-03
±³À°ÀÏÀÚ : 2023-06-03
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 12Ãþ
±³À°ÁÖÁ¦ : ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ¿¬±¸ÇÐȸ(º¯°æ 22.9.15 ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸,»ýü,±âÃÊÇÐȸ)
´ã´çÀÚ : ¹Ú±¤È¯
¿¬¶ôó : 010-9170-7884
À̸ÞÀÏ : khpark800@gmail.com
±³À°Á¾·ù : Á¤Çü¿Ü°ú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í Á¤È¸¿ø: 60,000¿ø / Çлý, Àü°øÀÇ, ÁØȸ¿ø: 50,000¿ø / ºñȸ¿ø: 70,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 09:00~09:15 ¾çÀÚ¼¾½Ì À̹Ì¡°ú ¹ÙÀÌ¿À ÀÇ·áºÐ¾ß È°¿ë À̵¿Çå(°í·Á´ë ¹°¸®Çаú)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 09:15~09:30 ¸»ÃʽŰæ Àç»ý ¹× °ñÀç»ýÀ» À§ÇÑ ÀÓÇöõÆ® Àü±âÀڱر⠱¸ÀÚÇö(°í·Á´ë ¹ÙÀÌ¿À°øÇкÎ)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 09:30~09:50 µðÁöÅÐ Æ®À©ÀÇ ÀÌÇØ¿Í ÀÓ»ó È°¿ë ±ÇÁöÈÆ(¼¿ï¾Æ»êº´¿ø ÀÇ°øÇבּ¸¼Ò)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 09:50~10:00 Discussion ()
ÈÞ½Ä 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 10:00~10:20 ÈÞ½Ä ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 10:20~10:35 ¿Ü°ú Áø´Ü°ú ¼ö¼ú¿¡ È°¿ë°¡´ÉÇÑ ÀΰøÁö´É ±â¼ú ¹Ú»óÇö(DGIST ·Îº¿¹×±â°èÀüÀÚ°øÇаú)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 10:35~10:50 °ñÀý Á¤º¹ ½Ã¼ú ·Îº¿ÀÇ Áö´ÉÁ¦¾î ¹× ±Ý¼ÓÁ¤ ³»°íÁ¤ ¼ö¼úÀÇ ¿øÀ§ºÎ ü°á ·Îº¿ ½Ã½ºÅÛ °³¹ß °í¼º¿µ(Àü³²´ë ±â°è°ú )
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 10:50~11:10 Á¤Çü¿Ü°ú ¼ö¼ú·Îº¿ °³¹ß Á¤»óÇö(¿¡¾î½º)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 11:10~11:20 Discussion ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 11:20~11:35 The mevalonate pathway as a therapeutic target for osteoporosis ±è¼ºÁø(¼¿ïÄ¡´ë ±¸°»ý¹°Çб³½Ç)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 11:35~11:50 The effect of novel RANKL-derived LGR4 agonist for osteoporosis treatment ÀÓ¿øºÀ(Á¶¼±ÀÇ´ë ÀÇ¿¹°ú)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 11:50~12:10 A novel disease-modifying osteoarthritis drug candidate targeting OSCAR ±èÁöÈñ(ÀÌÈ¿©´ë »ý¸í°úÇаú)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 12:10~12:20 Discussion ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 12:20~13:20 Áᫎ ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 13:20~13:40 Role of Runx/Cbfb complex during osteoarthritis ÃÖÁ¦¿ë(°æºÏÀÇ´ë »ýÈÇС¤¼¼Æ÷»ý¹°Çб³½Ç)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 13:40~14:00 Blockade of activin receptor IIB protects arthritis pathogenesis ¾ç½Ã¿µ(¾ÆÁÖÀÇ´ë ¾à¸®Çб³½Ç)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 14:00~14:20 Protective effects of cholesterol-lowering drugs on osteoarthritis ·ùÁ¦È²(Àü³²Ä¡´ë Ä¡°ú¾à¸®Çб³½Ç)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 14:20~14:35 Discussion ()
ÈÞ½Ä 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 14:35~14:55 ÈÞ½Ä ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 14:55~15:10 Translational research to develop a novel sarcopenia treatment À̱¤Ç¥(Çѱ¹»ý¸í°øÇבּ¸¿ø)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 15:10~15:25 Sarcopenia: clinical implications in osteoporosis management È«³²±â(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 15:25~15:45 Development of a machine learning driven novel blood biomarker of sarcopenia ·ùµ¿·Ä(±¤ÁÖ°úÇбâ¼ú¿ø ÀÇ»ý¸í°øÇаú)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 15:45~15:55 Discussion ()
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 15:55~16:10 Exosome researches for musculoskeletal disorders À̱ٿì(¿µ³²ÀÇ´ë Á¤Çü¿Ü°ú)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 16:10~16:25 FreSHtracer ±â¼ú·Î ¼±º°µÈ °í±â´É¼º ¼ºÃ¼Áٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ °ñ°üÀý¿° ¼¼Æ÷Ä¡·áÁ¦ °³¹ß ¹Î¼º±â(¼¿ÅõÀÎ)
±³À°½Ã°£ 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 16:25~16:45 ¼Õ»ó ¿¬°ñ¿¡ ´ëÇÑ TGF¥â-3ÀÇ Àç»ý È¿´É ¹× ³óµµ ÀÇÁ¸¼º ÀüÀÓ»ó Æò°¡ À¯¹Ì¿µ(½ÃÁö¹ÙÀÌ¿À)
Åä·Ð 06¿ù 03ÀÏ °ÀǽÇ(´ë¾ç AIȦ) 16:45~16:55 Discussion ()